Skip to main content
Early trial of Covid-19 vaccines by Pfizer, BioNtech promising: Scientists - Business Standard 04-Jul-2020
Early trial of Covid-19 vaccines by Pfizer, BioNtech promising: Scientists - Business Standard
The research said patients treated with the vaccine candidate produced nearly 1.8 to 2.8 fold greater levels of antibodies that could neutralise SARS-CoV-2
More...